Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Results

Singapore Institute of Advanced Medicine Holdings reports FY2024 loss of $37.4 mil

Felicia Tan
Felicia Tan • 2 min read
Singapore Institute of Advanced Medicine Holdings reports FY2024 loss of $37.4 mil
SAM Holdings' executive director, CEO and founder, Dr Djeng Shih Kien. Photo: Albert Chua/The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The Singapore Institute of Advanced Medicine Holdings (SAM) has reported a loss after tax and total comprehensive loss for the year of $37.4 million for the FY2024 ended June 30, more than twice its losses of $18.1 million in year before.

SAM’s 2HFY2024 loss also deepened by 75% y-o-y to $16.2 million from $9.3 million in the 2HFY2023.

While revenue for the full year rose by 3% y-o-y to $16.6 million, the company posted a loss before tax of $37.4 million due mainly to higher other losses and fees, especially finance costs which rose by 377% y-o-y to $11.6 million.

As at June 30, the company had $78.7 million in net assets. Its net asset value (NAV) per share stood at 7.51 cents.

Cash and cash equivalents as at the same period stood at $3.2 million, down from $11.1 million as at June 30, 2023, as the company repaid term loans and used cash for working capital.

In its financial statement, SAM said there was a decrease in patients at its Lucky Plaza clinic compared to the expected increase stated in its offer document. This was attributed to the experience of the newer sonographers which reduces the possibility of seeing more patients, therefore limiting the screenings that can be done, says SAM.

See also: IHH Healthcare’s 3QFY2024 patmi remains flat at RM534 mil

Even though SAM expected to see increases in its diagnostic imaging services at its advanced medicine imaging (AMI) centre at 1 Biopolis Drive, demand for MRI services fell y-o-y due to its “lumpy nature” while demand for PET-CT scanning services increased.

In its offer document, SAM also said it expected more patients seeking treatments for theranostics services and more patients for its radiotherapy services, although it also saw fewer patients during the year.

However, it expected increasing enquiries for its proton beam therapy services and it saw a “rising number” of patients doing so during the year. Finally, the company said it expected to see an increase in charges for its healthcare services, which have increased over the past 12 months.

See also: Marco Polo Marine reports lower 2HFY2024 earnings of $10.7 mil, down 42% y-o-y

“In line with the industry, the group intends to increase the pricing for its imaging services in early-2025, thereby positively impacting profit margins going forward,” says SAM.

As at 9.07am, shares in SAM are trading flat at 7.5 cents.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.